|
 |
|
|||||||
|
|||||||||
© 2005 by the American Diabetes Association, Inc.
Pathophysiology/Complications |
The Role of Autoimmunity at Diagnosis of Type 1 Diabetes in the Development of Thyroid and Celiac Disease and Microvascular Complications
1 Institute of Endocrinology and Diabetes, Children’s Hospital at Westmead, Westmead, New South Wales, Australia
2 Department of Paediatrics and Child Health, University of Sydney, Camperdown, New South Wales, Australia
3 School of Women’s and Children’s Health, University of New South Wales, Randwick, New South Wales, Australia
4 Sydney Children’s Hospital, Randwick, New South Wales, Australia
Address correspondence and reprint requests to Sarah J. Glastras, Institute of Endocrinology and Diabetes, Children’s Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. E-mail: swatzlaf{at}gmp.usyd.edu.au
OBJECTIVE—The purpose of this study was to explore whether the presence of thyroid and endomysial autoantibodies at diagnosis of type 1 diabetes in children predicts development of thyroid and celiac disease, respectively, and whether diabetes-associated autoantibodies at diagnosis predict development of microvascular complications up to 13 years later.
RESEARCH DESIGN AND METHODS—Autoantibodies were measured at diagnosis of type 1 diabetes in 173 children aged 0–15 years and included thyroperoxidase antibody (TPOA), endomysial antibody (EMA), islet cell autoantibody, GAD antibody (GADA), and insulin autoantibody. Thyroid disease was defined as thyroid stimulating hormone level 
5 µU/ml. Celiac disease was confirmed by small-bowel biopsy. Assessment of microvascular complications included stereoscopic fundal photography, pupillometry, thermal threshold, and albumin excretion rate (AER).
RESULTS—The incidence rates for thyroid and celiac disease were 0.9 and 0.7 per 100 patient-years, respectively. Within 13 years, 6 of 13 children with positive TPOA tests at diagnosis developed thyroid disease compared with 5 of 139 children with negative TPOA tests (P < 0.001). All four patients with positive EMA titers at diagnosis had biopsy-proven celiac disease. Five of 11 patients who developed thyroid disease and 4 of 8 who developed celiac disease had negative TPOA and EMA tests at diagnosis, respectively. Retinopathy was detected in 39% and elevated AER in 36%. The presence of diabetes-associated autoantibodies at diagnosis did not predict microvascular complications though GADA titer levels predicted pupillary abnormality.
CONCLUSIONS—Elevated TPOA and EMA levels at diagnosis of type 1 diabetes predict the development of thyroid and celiac disease, respectively. In children with negative antibody titers at diagnosis, screening at 2-year intervals is recommended.
Abbreviations: AER, albumin excretion rate • AGA, antigliadin antibody • EMA, endomysial antibody • GADA, GAD antibody • ICA, islet cell autoantibody • IAA, insulin autoantibody • TPOA, thyroperoxidase antibody • TSH, thyroid-stimulating hormone
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Waldron-Lynch, A. O'Loughlin, and F. Dunne Review: Gluten and glucose management in type 1 diabetes The British Journal of Diabetes & Vascular Disease, March 1, 2008; 8(2): 67 - 71. [Abstract] [PDF]
|
|
|
|
 |
|
 G. C. Gonzalez, I. Capel, J. Rodriguez-Espinosa, D. Mauricio, A. de Leiva, and A. Perez Thyroid Autoimmunity at Onset of Type 1 Diabetes as a Predictor of Thyroid Dysfunction Diabetes Care, June 1, 2007; 30(6): 1611 - 1612. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Eppens, M. E. Craig, J. Cusumano, S. Hing, A. K.F. Chan, N. J. Howard, M. Silink, and K. C. Donaghue Prevalence of Diabetes Complications in Adolescents With Type 2 Compared With Type 1 Diabetes. Diabetes Care, June 1, 2006; 29(6): 1300 - 1306. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |